Intel

Inside This Article: Alabama’s attorney general filed a lawsuit alleging that a medical spa administered non-FDA-approved versions of GLP-1 weight loss drugs without informing patients that the formulations were not authorized. The situation underscores growing concerns as medspas rapidly expand weight loss offerings amid strong consumer demand and uneven regulatory oversight. Allegations involving drug misrepresentation or lack of informed consent can…

Key Takeaways: Artificial intelligence (AI) tools offer new diagnosis and treatment possibilities, but safeguards must be in place for clinical judgment to override AI systems. Data privacy concerns are growing for healthcare providers and may be amplified by the increased use of AI-powered ambient listening technology. Medspa services carry risks related to licensing, supervision, and sexual misconduct claims. GLP-1…

From classrooms to clinics, AI is transforming healthcare. In this short clip from our recent Healthcare Liability webinar, Caileb Newby, Broker, Professional Liability, Burns & Wilcox Brokerage, San Francisco, CA, shares how the technology is enhancing both medical training and clinical decision-making. https://vimeo.com/1087198820/5b13535910?share=copy  

From evolving treatments to increased litigation and data privacy concerns, the risks facing healthcare professionals are more complex than ever. Watch the below webinar as our guest experts discuss key trends, challenges, and opportunities in the Healthcare Liability Insurance market. Featured Experts: Caileb Newby, Broker, Professional Liability, Burns & Wilcox Brokerage, San Francisco, CA Chris Valenzuela, Broker, Professional Liability, Burns…